The Significance of Oxidized Low-Density Lipoproteins and Receptors LOX-1 in Type 2 Diabetes Mellitus
Diabetes mellitus · 18.01.2025 · 27 (6) · 589-597
DOI: 10.14341/dm13203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes mellitus, online erschienen am 18.01.2025. Verfasst von D. L. Fetlam und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
INTRODUCTION. Type 2 diabetes mellitus (T2DM) occurs in 8.5% of the adult population with a tendency to increase. A characteristic feature of T2DM is dyslipidemia. One of its manifestations includes accumulation of increased concentration of oxidized low-density lipoproteins (ox-LDL) in circulation. Ox-LDL molecules act on cells through LOX-1 receptors. THE PURPOSE OF THE REVIEW is to demonstrate results of studies presented in publications of 2010–2024 (PubMed, RSCI) indicating the pathogenetic role of ox-LDL and its LOX-1 receptors in T2DM development and course. MATERIALS AND METHODS . In the analysis of more than 2800 literature sources (PubMed), in which together with term “diabetes mellitus” keywords are found: ox-LDL (1150 sources) or LOX-1 (159 sources), as well as OLR1 (106 sources), 50 sources were identified that are directly related to T2DM and the studied functionally related markers — the LOX-1 receptor and its ligand ox-LDL. RESULTS. LOX-1 is scavenger receptor that uses ox-LDL as its proper ligand. Gene OLR1 encodes ox-LDL receptor, LOX-1. The linking of T2DM and circulating levels of ox-LDL is bidirectional. The emerging insulin resistance directly correlates with oxidation of low-density lipoproteins, which is observed in more than 80% of patients and depends on the duration of T2DM. High plasma ligand levels are associated with increased type 2 diabetes risk. The mechanism of this association is thought to be related to functionally significant expression of LOX-1 on pancreatic cells. It was shown that pancreatic β-cells in the presence of ox-LDL increased production of the inducible early repressor of the cAMP signaling pathway, ICER. As result of ICER action, insulin production and secretion ceased. Increased ox-LDL concentrations are a pathogenetically significant factor in the development of atherosclerotic vascular lesions, as they stimulate the generation of foam cells. Ox-LDL-LOX-1-mediated interactions on the vascular surface led to endothelial dysfunction with subsequent development of tissue hypoperfusion and organ dysfunction. CONCLUSION. Circulating ox-LDL, in interaction with its receptor LOX-1, makes a significant contribution to the development of T2DM, promoting its progression. Increased concentration of ox-LDL in blood increases the risk of severe T2DM, leading to endothelial dysfunction and promoting the development of atherosclerotic vascular lesions.
Zitieren
APA
Fetlam, D. L., Chumachenko, A. G., & Pisarev, V. M. (2025). The Significance of Oxidized Low-Density Lipoproteins and Receptors LOX-1 in Type 2 Diabetes Mellitus. Diabetes mellitus, 27(6), 589-597. https://doi.org/10.14341/dm13203
Vancouver
Fetlam DL, Chumachenko AG, Pisarev VM. The Significance of Oxidized Low-Density Lipoproteins and Receptors LOX-1 in Type 2 Diabetes Mellitus. Diabetes mellitus. 2025;27(6):589-597. doi:10.14341/dm13203
BibTeX
@article{Fetlam2025,
author = {Fetlam, D. L. and Chumachenko, A. G. and Pisarev, V. M.},
title = {The Significance of Oxidized Low-Density Lipoproteins and Receptors LOX-1 in Type 2 Diabetes Mellitus},
journal = {Diabetes mellitus},
year = {2025},
volume = {27},
number = {6},
pages = {589--597},
doi = {10.14341/dm13203}
}
EUVIMED